About
Organ fibrosis and inflammatory diseases
Areas of Focus
Categories
Small Molecule PharmaceuticalSan Diego & Southern California
Team (11)
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
429
By Phase
PHASE1/PHASE2: 2
By Status
RECRUITING: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT07047703Lead Sponsor
EAST-1 (ERAP-inhibition in Axial Spondyloarthritis Trial - 1)
PHASE1/PHASE2Recruiting
141 participants
Started: Jul 28, 2025 · Completed: Sep 30, 2028
NCT06923761Lead Sponsor
EMITT-1 (ERAP Mediated Immunopeptidome Targeting Trial - 1)
PHASE1/PHASE2Recruiting
288 participants
Started: May 21, 2023 · Completed: Apr 30, 2028
Locations (1)
Headquarters
San Diego, CA, United States
Map
Loading map...